The Y831C Mutation of the POLG Gene in Dementia

Eugenia Borgione1, Mariangela Lo Giudice1, Sandro Santa Paola1

  • 1Oasi Research Institute-IRCCS, 94018 Troina, Italy.

Biomedicines
|May 16, 2023
PubMed
Abstract

Insights

Mutations in the POLG gene, vital for mitochondrial DNA maintenance, were investigated in neurodegenerative diseases. The Y831C mutation was found more frequently in patients, suggesting a role in neurodegeneration.

Area of Science:

  • Genetics and Molecular Biology
  • Neuroscience
  • Mitochondrial Biology

Background:

  • The POLG gene encodes DNA polymerase gamma, essential for mitochondrial DNA (mtDNA) replication and repair.
  • Mutations in POLG are linked to various mitochondrial disorders, including SANDO, PEO, SCAE, Alpers syndrome, and sensory ataxic neuropathy.
  • Emerging evidence suggests POLG mutations may contribute to neurodegenerative diseases, but systematic studies are limited.

Purpose of the Study:

  • To determine the frequency of POLG gene mutations in patients with neurodegenerative disorders.
  • To explore the potential association between POLG mutations and conditions like Parkinson's disease, atypical parkinsonisms, and various dementias.

Main Methods:

  • Screening of 33 patients diagnosed with neurodegenerative diseases for POLG gene mutations.
  • Mutational analysis to identify specific POLG variants within the patient cohort.

Main Results:

  • The heterozygous Y831C POLG mutation was identified in two patients: one with frontotemporal dementia and one with Lewy body dementia.
  • The allele frequency of Y831C was significantly higher in the patient group (3.03%) compared to the healthy population (0.22% from 1000 Genomes Project).

Conclusions:

  • The findings suggest that the Y831C POLG mutation may play a pathogenic role in neurodegeneration.
  • This study expands the known genotype-phenotype spectrum for POLG gene mutations.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
543
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
229
Translation01:31

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
15.0K
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
9.7K